Pegfilgrastim, but not Plinabulin, Generates a Blood Myeloid Cell (BMC) Repertoire with a Predominant Immunosuppressive Phenotype
Plinabulin (Plin), a Novel Non-G-CSF Molecule for the Prevention of Chemotherapy-Induced Neutropenia (CIN), Has the Potential to Positively Impact Tumor Micro Environment
Plinabulin-Associated Neutrophil Demargination: Evidence for a Clinically Relevant Mechanism of Action for the Prevention of Chemotherapy-Induced-Neutropenia
Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy-Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients
Plinabulin (Plin), a Small Molecule with Anti-Cancer Activity and a Novel Mechanism of Action (MoA) in Docetaxel (Tax) Induced Neutropenia: Phase (φ) 2 Results from a Head-to-Head Comparison with Pegfilgrastim (Peg)
© 2020 BeyondSpring Inc. All rights reserved.